Rockefeller University: Researchers Develop a Potential IVIG Replacement for Treating Autoimmunity That's Significantly More Potent
November 07, 2025
November 07, 2025
NEW YORK, Nov. 7 (TNSjou) -- Rockefeller University issued the following news:
* * *
Researchers develop a potential IVIG replacement for treating autoimmunity that's significantly more potent
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently FDA-approved for four diseases but widely prescribed off-label to . . .
* * *
Researchers develop a potential IVIG replacement for treating autoimmunity that's significantly more potent
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently FDA-approved for four diseases but widely prescribed off-label to . . .